Search

everythinglearnresearchcommunity

for

Search:↓

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Plant-based ingredients are effective and safe for modern skincare products.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Diabetes often causes various skin problems and complications.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Non-thermal plasma treatment makes mouse skin thicker and increases growth factors without harming the tissue.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.